CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 450 enrolled
Drug / intervention
Acceptance & Commitment Therapy (ACT) +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01533974
NCT01533974Phase 2Completed
CompareCT.gov

Acceptance & Commitment Therapy for Smoking Cessation (Aka PATH Study - Partnering to Achieve Tobacco-free Health)

Fred Hutchinson Cancer Center·interventional·Posted Feb 16, 2012·Updated Jun 17, 2016

In Brief

A Phase 2 clinical trial evaluating Acceptance & Commitment Therapy (ACT) and Cognitive Behavioral Therapy (CBT) for Smoking Cessation. Completed, enrolled 450 participants across 1 site.

Detailed Summary

The overall aim of this 5-year project is to capitalize on the strong theoretical and promising empirical evidence for Acceptance \& Commitment Therapy (ACT) as an intervention for smoking cessation by comparing the effectiveness of ACT against standard cognitive behavioral therapy (CBT) counseling when both are offered with nicotine replacement therapy (NRT) and delivered within a real world healthcare setting.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSmoking Cessation
CountriesUnited States
CollaboratorsKaiser Permanente

Timeline

Phase 2CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 16, 2012
Enrollment StartJun 1, 2011
Primary CompletionJan 1, 2015
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 14.4 years ago

Interventions

Acceptance & Commitment Therapy (ACT)other

We will use a five-session (90 minutes per session) group-delivered adaptation of Dr. Bricker's ACT treatment program.

Cognitive Behavioral Therapy (CBT)other

The control condition will be the current group-delivered CBT smoking cessation program at GH.